What do we actually know about adamantyl carbonyl proline in humans?

Essentially nothing. There are no published human clinical trials and no specific molecular target has been identified. Claims about cognitive effects come from community reports and marketing rather than controlled experiments.

Why attach an adamantane cage to proline?

Adamantane is a standard medicinal-chemistry tool: it increases a molecule's stability and fat solubility, which could in theory improve blood-brain barrier crossing. That is a pharmacokinetic property, however, and does not prove the compound has any cognitive effect.

It is not approved as a medicine or dietary supplement, and its safety in humans is unknown. It is typically available as a chemical intermediate or a gray-market research chemical of uncertain purity.

EmergingResearch compoundReference only

Adamantyl Carbonyl Proline

Name: Adamantyl Carbonyl Proline
Creator: MolekulaX

Adamantane-proline conjugate, putative memory enhancer, no human data.

NootropicNeuroprotectiveMemoryNeuroprotectionBDNFGlutamatenoo.affects.memory

Pharmacology

ClassMemory · Neuroprotection

Primary targetBDNF/neurotrophic signaling modulation (putative)

Targets3 receptor targets

Half-lifeNot characterized

OnsetNo human data (no validated protocol exists)

EvidenceReference only

Affected systemsBDNFGlutamatenoo.affects.memory

Contents

WHAT IS ADAMANTYL CARBONYL PROLINE?

Detailed overview

Adamantyl carbonyl proline (1-(1-adamantylcarbonyl)proline, CAS 35084-48-1) is a small molecule that joins an adamantane cage to proline through a carbonyl linkage, and it circulates in nootropic communities as a putative cognitive enhancer. The adamantane portion is a common medicinal-chemistry device for increasing stability and fat solubility, which could in principle help a molecule cross the blood-brain barrier, but no specific molecular target has been established for this compound, so its pharmacology is largely speculative. It is essentially uncharacterized in the peer-reviewed literature: there are no published human trials, and the claims in circulation lack empirical support. It appears mainly as a synthesis intermediate and gray-market research chemical rather than a proven supplement.

Mechanism

No established target (putative BDNF modulation)

Evidence

Reference-level (no human data)

Legal status

Unapproved research chemical / intermediate

Receptor profile

BDNF / neurotrophic signalingWeak
Glutamatergic transmissionWeak
Blood-brain barrier penetration (adamantane cage)Moderate

Safety

Side effects, stop signs, contraindications

Side effects · 4

Human safety is essentially unknown: no clinical data and no published toxicity profile
Gray-market sourcing: variable purity and uncertain contents, possible contaminants
All claimed effects are unproven; the side-effect spectrum in humans cannot be predicted
No established dosing protocol exists, so overdose risk cannot be estimated

Contraindications · 3

Pregnancy and breastfeeding: safety not established, avoid
Not an approved medicine: experimental substance, not recommended without clinical supervision
Unknown drug interactions: combining with other agents is risky absent a documented pharmacological profile

Related Nootropics

Same therapeutic category

FAQ

Adamantane-proline conjugate, putative memory enhancer, no human data.

Have a question about Adamantyl Carbonyl Proline?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic

FormulaC16H23NO3

UpdatedJuly 10, 2026

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA

Updated: July 10, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.